HRT Financial’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-71,867
Closed -$306K 3994
2025
Q4
$306K Buy
+71,867
New +$273K ﹤0.01% 2362
2025
Q1
Sell
-110,242
Closed -$113K 2659
2024
Q4
$113K Buy
110,242
+83,402
+311% +$89.7K ﹤0.01% 2038
2024
Q3
$31K Buy
+26,840
New +$34.1K ﹤0.01% 2153
2024
Q2
Sell
-16,831
Closed -$36K 2376
2024
Q1
$36K Buy
+16,831
New +$31.1K ﹤0.01% 1967
2022
Q2
Sell
-68,259
Closed -$182K 3061
2022
Q1
$182K Sell
68,259
-75,901
-53% -$291K ﹤0.01% 2515
2021
Q4
$624K Sell
144,160
-5,016
-3% -$29.4K ﹤0.01% 1586
2021
Q3
$759K Buy
+149,176
New +$799K ﹤0.01% 1563
2021
Q1
Sell
-27,640
Closed -$181K 2770
2020
Q4
$181K Buy
27,640
+5,382
+24% +$38.4K ﹤0.01% 1514
2020
Q3
$148K Buy
+22,258
New +$165K ﹤0.01% 1447
2020
Q1
Sell
-18,478
Closed -$153K 876
2019
Q4
$153K Buy
+18,478
New +$125K 0.01% 980

Other funds holding CTMX